StreetAlpha.app
Home › Stocks › TECH

BIO-TECHNE Corp (TECH)

Healthcare
$72.67
▼ −0.04%
LAST CLOSE · NOV 20

Bio-Techne sells life science reagents, instruments and diagnostic products to researchers, drug developers and diagnostics makers. It last closed at $72.67 on Nov 20, down 0.04% on the day. The next earnings report for TECH is expected around Wed, Feb 3, 2027. For the quarter ended Sep 2026, TECH reported EPS of $0.18 on revenue of $299.7M, with revenue up 4.6% from a year ago. Over its last 8 reports the stock moved an average of 5.8% the session after earnings. Over the last 12 months TECH insiders bought $0 of stock on the open market and sold $437K, according to SEC Form 4 filings.

AI Auto Pilots
Is TECH in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TECH.

Key Stats

Last 12 months
Results
Revenue
$1.2B
+0.9% vs a year ago
Net income
$172.0M
+120.5% vs a year ago
EPS (diluted)
$1.10
+124.5% vs a year ago
Free cash flow
$308.2M
25.1% margin
Valuation
Market cap
$11.4B
157.1M shares
P/E
66.1
Price over 12 month EPS
Price to sales
9.3
Market cap over revenue
Dividend yield
0.44%
$0.32 a share over 12 months
Balance sheet
Cash & equivalents
$350.0M
At Sep 30
Shareholder equity
$2.2B
Shares outstanding
157.1M
At Nov 2
Fiscal year endsJune
ExchangeNasdaq
Financials history
FY2022: $1.1B$1.1BFY2022FY2023: $1.1B$1.1BFY2023FY2024: $1.2B$1.2BFY2024FY2025: $1.2B$1.2BFY2025FY2026: $1.2B$1.2BFY2026

From TECH's SEC filings, latest 10-Q/A for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Feb 3
Estimated date · Time not announced
Reported EPS
$0.18
Quarter ended Sep 2026
Year ago EPS
$0.24
−25.0% on a GAAP basis
Revenue
$299.7M
+4.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.22Dec '24Mar 2025: $0.14Mar '25Jun 2025: -$0.11Jun '25Sep 2025: $0.24Sep '25Dec 2025: $0.24Dec '25Mar 2026: $0.32Mar '26Jun 2026: $0.35Jun '26Sep 2026: $0.18Sep '26Latest $0.18
Revenue by quarter
Dec 2024: $297.0MDec '24Mar 2025: $316.2MMar '25Jun 2025: $317.0MJun '25Sep 2025: $286.6MSep '25Dec 2025: $295.9MDec '25Mar 2026: $311.4MMar '26Jun 2026: $321.2MJun '26Sep 2026: $299.7MSep '26Latest $299.7M
How TECH moved after its last 8 reports
Average move the session after a report ±5.8%
Aug 12, 2026Time not announced+0.1%
May 6, 2026Time not announced−16.4%
Feb 4, 2026Time not announced+6.3%
Nov 5, 2025Time not announced−1.9%
Aug 6, 2025Time not announced−8.7%
May 7, 2025Time not announced+2.2%
Feb 5, 2025Time not announced+3.7%
Oct 30, 2024Time not announced+7.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on TECHStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on TECH
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on TECH

Technical Analysis

TECH · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is 13% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 50). The nearest support is the Pivot S1 at $72.63, and the nearest resistance the swing high (Sep 22) at $72.69.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityLow, 0.2%/day
Key levels
$72.8852 week high+0.3%
$72.74Pivot R1+0.1%
$72.7220 day average+0.1%
$72.70Pivot+0.0%
$72.69Swing high (Sep 22)+0.0%
$72.67Last close
$72.63Pivot S1−0.1%
$72.63Swing low (Nov 3)−0.1%
$72.5850 day average−0.1%
$72.27100 day average−0.6%
$63.56200 day average−12.5%
$43.2052 week low−40.6%
Indicators
RSI (14)50.13Middle of its rangeNeutral
MACD0.05Below its signal lineBearish
Stochastic40.2Middle of its rangeNeutral
ADX (14)32.4Trending down
Williams %R-72.4Oversold below −80, overbought above −20Neutral
CCI (20)-42.2Oversold below −100, overbought above 100Neutral
Rate of change−0.1%Change over 10 sessionsBearish
ATR (14)$0.13Typical daily range, 0.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for TECH

What happened before

See how TECH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow TECH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How TECH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for TECHHow many large options trades hit TECH, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

TECH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼261 buying vs 320 selling
  • ▼Held by funds -12.5 pts
  • ▼Funds holding -15
  • ●Superinvestors: 3 added, 3 cut
  • ▼Put/call 0.04 to 0.05
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding588603−2.5%
In funds' top 101217−29.4%
Held by funds99.1%111.7%−12.5 pts
New / increased88 / 173127 / 162−9.7%
Reduced / sold out217 / 103245 / 114−10.9%
Put/call ratio0.050.04+24.9%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TECH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

TECH Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$437K2 sales · 1 insider
2026-02 sold $117K2026-05 sold $320KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
May 8Amy E. HerrDirectorSale6,636$48.28$320K
Feb 17Amy E. HerrDirectorSale1,976$59.11$117K
Aug 25, 2025Robert V BaumgartnerDirectorSale17,040$56.21$958K
Aug 25, 2025Roeland NusseDirectorSale17,040$56.36$960K
Jun 9, 2025Amy E. HerrDirectorSale1,280$49.77$64K
Feb 14, 2025Amy E. HerrDirectorSale1,860$65.96$123K
Every insider buy and sale for TECH over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See TECH insider trades →

From SEC Form 4 filings by TECH's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

TECH Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$41.7M
0.4% yield
Left in program
$363.3M
3.2% of value
Shares outstanding, 12 months
+0.8%
More shares
Last quarter
$0
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
#346 of 358
 
Spent each quarter, last 3 yearsTop bar $475.8M
Dec 2023: $80.0M, average price $57.28Mar 2024: $80.0M, average price $57.28Jun 2024: $80.0M, average price $57.28Sep 2024: $0Dec 2024: $151.3M, average price $67.62Mar 2025: $200.1M, average price $67.29Jun 2025: $475.8M, average price $56.40Sep 2025: $48K, average price $48.01Dec 2025: $0Mar 2026: $0Jun 2026: $125.0M, average price $45.82Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 6, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TECH is in one of them and how their past TECH trades turned out.

TECH in the AI portfolios
Loading…

TECH News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TECH in an article yet. Here's the latest on the wider market.

TECH in the news

TECH Congress Trades

All congress trades →
Trades, 12 months
6
Buys
2
33%
Sells
4
67%
People
1
Last filed May 6
Who traded TECH · since 2015
Latest 5 filings of 17
$1K – $15KTraded Apr 8, 2026Filed May 6, 2026
April DelaneySell (partial)
$1K – $15KTraded Mar 26, 2026Filed Apr 6, 2026
April DelaneySell (partial)
$1K – $15KTraded Feb 24, 2026Filed Mar 10, 2026
April DelaneySell (partial)
$1K – $15KTraded Jan 28, 2026Filed Feb 2, 2026
$1K – $15KTraded Dec 5, 2025Filed Jan 5, 2026
PersonTypeAmountTradedFiledDelay
April DelaneyD · MDSell$1K – $15KApr 8, 2026May 6, 202628 d
April DelaneyD · MDSell (partial)$1K – $15KMar 26, 2026Apr 6, 202611 d
April DelaneyD · MDSell (partial)$1K – $15KFeb 24, 2026Mar 10, 202614 d
April DelaneyD · MDSell (partial)$1K – $15KJan 28, 2026Feb 2, 20265 d
April DelaneyD · MDBuy$1K – $15KDec 5, 2025Jan 5, 202631 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About BIO-TECHNE

Bio-Techne is a life science company based in Minneapolis, Minnesota. It develops, manufactures and sells research reagents, proteins, antibodies and protein analysis instruments used in laboratory research and cell and gene therapy work. It also makes diagnostic controls, calibrators and assays, along with spatial biology tools for analyzing tissue samples. Its customers include academic researchers, pharmaceutical and biotech companies, contract research organizations and diagnostics instrument makers.

Headquarters
Minneapolis, MN